Showing results (61-70 of 239) with videos related to

Sort By:
Pageof 24
Oncology Letters|March 19, 2019
p53 overexpression is a prognosticator of poor outcome in esophageal cancerNathaniel Melling, Sonja Norrenbrock, Martina Kluth, et al.
Human Pathology|December 28, 2016
βIII-tubulin overexpression is linked to aggressive tumor features and genetic instability in urinary bladder cancerAndrea Hinsch, Aref Chaker, Christian Burdelski, et al.
BMC Cancer|March 3, 2019
Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancerCornelia Schroeder, Jan Grell, Claudia Hube-Magg, et al.
Carcinogenesis|September 23, 2015
Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parametersNathaniel Melling, Erik Thomsen, Maria Christina Tsourlakis, et al.
International Journal of Cancer|September 19, 2015
Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancersChristoph Burdelski, Sandra Kleinhans, Martina Kluth, et al.
International Journal of Molecular Sciences|April 21, 2015
VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomyMaria Christina Tsourlakis, Puya Khosrawi, Philipp Weigand, et al.
Anticancer Research|April 30, 2014
MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotypeStefan Steurer, Ahmad Shoaib Seddiqi, Julius Magnus Singer, et al.
Urologic Oncology|May 12, 2015
Heterogeneity in D'Amico classification-based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibilityJonas Schiffmann, Philipp Wenzel, Georg Salomon, et al.
Molecular Oncology|March 9, 2023
Comparative evaluation of PD-L1 expression in cytology imprints, circulating tumour cells and tumour tissue in non-small cell lung cancer patientsMustafa Abdo, Yassine Belloum, David Heigener, et al.
Oncotarget|April 1, 2015
HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomyCristina Villares Zabalza, Meike Adam, Christoph Burdelski, et al.
Pageof 24